The news of RBC Capital analyst Sean Dodge reiterating an Outperform rating on Catalent and maintaining a $41 price target is positive for the stock. This reaffirms the analyst's confidence in the company's performance and potential for growth, which could lead to an increase in investor interest and a potential short-term increase in the stock price.